Summary
Haloperidol (R 1625) is 50 to 100 times more active than chlorpromazine as an inhibitor of exploratory motor behaviour in rats. Emotional defaecation in rats is inhibited by both drugs at similar dose levels.
Similar content being viewed by others
References
Alleva, P. M.: Primi risultati sul trattamento di 60 casi di malattie mentali con un nuovo neurolettico, l'haloperidol (R 1625). Freniatria 84, 1 (1960).
Broadhurst, P. L.: Determinants of emotionality in the rat. II. Antecedent factors. Brit. J. Psychol. 49, 12–20 (1958).
Delay, J., P. Pichot, T. Lempérière, B. Elissalde et F. Peigne: Un neuroleptique majeur non phénothiazinique et non réserpinique, l'haloperidol, dans les traitement des psychoses. Ann. méd.-psychol. 118, 145–152 (1960).
Divry, P., J. Bobon et J. Collard: Le ≪R 1625≫: nouvelle thérapeutique symptomatique de l'agitation psychomotrice. Acta neurol. belg. 58, 878–888 (1958).
Divry, P., J. Bobon, J. Collard, A. Pinchard et E. Nols: Etude et expérimentation cliniques du R 1625 ou haloperidol, nouveau neuroleptique et ≪neurodysleptique≫. Acta neurol. belg. 59, 337–366 (1959).
Flegel, H., A. Rasper et H. Lauber: Etude clinique du R 1625 ou haloperidol. Communication au Congrès de Psychiatrie et de Neurologie de Langue Française, LVII. Session, Tours (France) 8–13 juin 1959.
Jacobs, R.: Klinische ervaring met R 1625 (Haloperidol). Psychiatrie en Verpleging No 1, p. 8–18 (1959); No 211, p. 20–32 (1959); No 2, p. 16–23 (1960).
Janssen, P. A. J., A. H. Jageneau, J. Huygens, P. J. A. Demoen, C. van de Westeringh and M. Wouters: Synthetic anti-diarrheal agents. Part I. Synthesis and pharmacological properties of R 1132 and related compounds. J. Med. Pharm. Chem. 1, 299–308 (1959a).
Janssen, P.A. J., and C. J. E. Niemegeers: Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. Part II. Inhibition of apomorphine-vomiting in dogs. Arzneimittel-Forsch. 9, 765–767 (1959b).
Janssen, P. A. J., C. E. J. Niemegeers and K. H. L. Schellekens: Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. Part III. Duration of antiemetic action and oral effectiveness of haloperidol (R 1625) and of chlorpromazine in dogs. Arzneimittel-Forsch. 1960a (in the press).
Janssen, P. A. J., C. van de Westeringh, A. H. M. Jageneau, P. J. A. Demoen, B. K. F. Hermans, G. H. P. van Daele, K. H. L. Schellekens, C. A. M. van der Eycken and C. J. E. Niemegeers: Chemistry and pharmacology of CNS depressants related to 4-(4-hydroxy-4-penylpiperidino) butyrophenone. Part I. Synthesis and screening data in mice. J. Med. Pharm. Chem. 1, 281–297 (1959c).
Kristjansen, P.: Expérimentation clinique du R 1625. Congrès de Psychiatrie et de Neurologie de Langue Française, LVII. Session, Tours (France) 8–13 juin 1959.
Paquay, J., F. Arnould et P. Burton: Etude clinique de l7action du R 1625 a doses modérées en psychiatrie. Acta neurol belg. 59, 882–891 (1959).
Paquay, J., F. Arnould et P. Burton: Etude de l'action du R 1625 (Halopéridol) sur 62 cas de schizophrénie. Congrès de Psychiatrie et de Neurologie de Langue Française, LVII. Session, Tours (France) 8–13 juin 1959.
Ryall, R. W.: Effect of drugs on emotional behaviour in rats. Nature (Lond.) 182, 1606–1607 (1958).
Siegel, S.: Nonparametric statistics for the behavioral sciences. McGraw-Hill series in psychology, 1956, p. 47 and 127.
Author information
Authors and Affiliations
Additional information
Thanks are due to Mr. Remi Frederickx for his technical assistance.
Rights and permissions
About this article
Cite this article
Janssen, P.A.J., Jageneau, A.H.M. & Schellekens, K.H.L. Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. Psychopharmacologia 1, 389–392 (1960). https://doi.org/10.1007/BF00441186
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00441186